Company / Operating Income per Share
Valion Bio, Inc. Operating Income per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$95.60
FY2024
5-year range
-$104.34 / -$0.58
FY2022-FY2024
Trend
+8.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.58 to $-95.60 over the past 2 years.
Based on SEC 10-K filings.
-95.60 in FY2024.
Declined from $-0.58 to $-95.60 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income per share increased 8.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$95.60 | +8.4% |
| FY2023 | -$104.34 | -17895.8% |
| FY2022 | -$0.58 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026